LF 16.0335, a novel potent and selective nonpeptide antagonist of the human bradykinin B2 receptor

British Journal of Pharmacology

Volumn 125, Issue 2, 1998, Pages 365-372

  Pruneau, Didier ^a   Luccarini, Jean Michel ^a   Fouchet, Chantal ^a   Defrêne, Evelyne ^a   Franck, Rose Marie ^a   Loillier, Bruno ^a   Duclos, Hervé ^a   Robert, Claude ^a   Cremers, Béatrice ^a   Bélichard, Pierre ^a   Paquet, Jean Luc ^a  

^a Laboratoire de Pharmacochimie   (France)

Author keywords

B2 receptor antagonist; Binding; Bradykinin; Human umbilical vein; In vitro; Nonpeptide; Phosphoinositosides

Indexed keywords

2 [[4 [4 (AMINOIMINOMETHYL)BENZOYL] 1 PIPERAZINYL]CARBONYL] 1 [2,4 DICHLORO 3 [(2,4 DIMETHYL 8 QUINOLINYL)OXYMETHYL]PHENYLSULFONYL]PYRROLIDINE; BRADYKININ; BRADYKININ B2 RECEPTOR ANTAGONIST; MUSCARINIC M1 RECEPTOR; MUSCARINIC M2 RECEPTOR; NEW DRUG; PHOSPHATIDYLINOSITIDE; UNCLASSIFIED DRUG;

ARTICLE; BINDING KINETICS; CELL MEMBRANE; CHO CELL; DRUG BINDING; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

AMIDINES; BINDING, COMPETITIVE; BRADYKININ; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; PHOSPHATIDYLINOSITOLS; PIPERAZINES; RECEPTOR, BRADYKININ B2; RECEPTORS, BRADYKININ; UMBILICAL VEINS; VASOCONSTRICTION;

EID: 15644383726     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702083     Document Type: Article

References (50)

1. AHLUWALIA, A., MAGGI, C.A., SANTICIOLI, P., LECCI, A. & GIULIANI, S. (1994). Characterization of the capsaicin-sensitive component of cyclophosphamide-induced inflammation in the rat urinary bladder. Br. J. Pharmacol., 111, 1017-1022.
2. AKBARY, A.M., WIRTH, K.J. & SCHÖLKENS, B.A. (1996). Efficacy and tolerability of Icatibant (Hoe 140) in patients with moderately severe chronic bronchial asthma. Immunopharmacology, 33, 238-242.
3. ARAMORI, I., ZENKOH, J., MORIKAWA, N., O'DONNELL, N., ASANO, M., NAKAMURA, K., IWAMI, M., KOJO, H. & NOTSU, Y. (1997). Novel subtype-selective nonpeptide bradykinin receptor antagonists FR167344 and FR173657. Mol. Pharmacol., 51, 171-176.
4. ASANO, M., INAMURA, N., HATORI, C., SAWAI, H., FUJIWARA, T., KATAYAMA, A., KAYAKIRI, H., SATOH, S., ABE, Y., INOUE, T., SAWADA, Y., NAKAHARA, K., OKU, T. & OKUHARA, M. (1997). The idendification of an orally active, nonpeptide bradykinin B; receptor antagonist, FR173657. Br. J. Pharmacol., 120, 617-624.
5. 2 kinin receptor antagonist, of antigen-induced nasal blockage. Br. J. Pharmacol., 111, 969-971.
6. BACHVAROV, D.R., SAINT-JACQUES, E., LARRIVEE, J.-F., LEVESQUE, L., RIOUX, F., DRAPEAUX, G. & MARCEAU. F. (1995). Cloning and pharmacological characterization of the rabbit bradykinin Bi receptor. J. Pharmacol. Exp. Ther., 275, 1623-1630.
7. 1 receptor in 293 cells: pharmacological and functional characterization. Br. J. Pharmacol., 122, 393-399.
8. BERRIDGE, M.J., DAWSON, R.M.C., DOWNES, C.P., HESLOP, J.P. & IRVINE, R.F. (1982). Lithium amplifies agonist-dependent phosphatidyl inositol responses in brain and salivary gland. Biochem. J., 206, 587-595.
9. BHOOLA, K.D., FIGUEROA, C.D. & WORTHY, K. (1992). Bioregulation of kinins: Kallikreins, kininogens, and kininases. Pharmacol. Rev., 44, 1-80.
10. 9-bradykinin in vitro and in vivo. Br. J. Pharmacol., 92, 257-264.
11. BRADFORD, M.M. (1976). A rapid and sensitive method for quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 721, 248-254.
12. 2 receptor antagonists on bradykinin-induced vasodilation and edema formation in isolated rabbit hindlimbs. Inflamm. Res., 44, 212-216.
13. CESARE, P. & MCNAUGHTON, P. (1996). A novel heat-activated current in nociceptive neurons and its sensitization by bradykinin. Proc. Natl. Acad. Sci. U.S.A., 93, 15435-15439.
14. 50) of an enzymatic reaction. Biochem. Pharmacol., 22, 3099-3108.
15. CHRISTIANSEN, S.C., PROUD, D. & COCHRANE, C.G. (1987). Detection of tissue kallikrein in the bronchoalveolar lavage fluids of asthmatic subjects. J. Clin. Invest., 79, 188-197.
16. 125I]-Hoe 140. Br. J. Pharmacol., 119, 1054-1062.
17. DRAY, A. & BEVAN, S. (1993). Inflammation and hyperalgesia: highlighting the team effort. TiPS. 14, 287-290.
18. FÉLÉTOU, M., MARTIN, C.A.E., MOLIMARD, M., NALINE, E., GERMAIN, M., THURIEAU, C., FAUCHÈRE, J.-L., CANET, E. & ADVENIER. C. (1995). In vitro effects of HOE 140 in human bronchial and vascular tissue. Eur. J. Pharmacol., 274, 57-64.
19. 2 type characterized by radioligand binding. Br. J. Pharmacol., 122, 1450-1454.
20. GIULIANI, S., SANTICIOLI, P., LIPPE, I.T., LECCI, A. & MAGGI, C.A. (1993). Effect of bradykinin and tachykinin receptor antagonist on xylene-induced cystitis in rats. J. Urol., 150, 1014-1017.
21. GOBEIL, F., PHENG, L.H., BADINI, I., NGUYEN-LE, X.K., PIZARD, A., RIZZI, A., BLOUIN, D. & REGOLI, D. (1996). Receptors for kinins in the human isolated umbilical vein. Br. J. Pharmacol., 118, 289-294.
22. GRIESBACHER, T., TIRAN, B. & LEMBECK, F. (1993). Pathological events in experimental acute pancreatitis prevented by the bradykinin antagonist, Hoe 140. Br. J. Pharmacol., 108, 405-411.
23. HALL, J.M. (1992). Bradykinin receptors: Pharmacological properties and biological roles. Pharmac. Ther., 56, 131-190.
24. HESS, J.F., BORKOWSKI, J.A., MACNEIL, T., STONESIFER, G.V., FRAHER, J & STRADER, C.D. (1994). Differential pharmacology of cloned human and mouse B2 bradykinin receptors. Mol. Pharmacol., 45, 1-8.
25. HESS, J.F., BORKOWSKI, J.A., YOUNG, G.S., STRADER, C.D. & RANSOM, R.W. (1992). Cloning and pharmacological characterization of a human bradykinin (BK-2) receptor. Biochem. Biophys. Res. Commun., 184, 260-268.
26. HOCK, F.J., WIRTH, K., ALBUS, U., LINZ, W., GERHARDS, H.J., WIEMER, G., HENKE, S., BREIPOHL, G., KÖNIG, W., KNOLLE, J. & SCHÖLKENS, B.A. (1991). Hoe 140 a new potent and long acting bradykinin-antagonist: in vitro studies. Br. J. Pharmacol., 102, 769-773.
27. KAMIYA, T., KATAYAMA, Y., KASHIWAGI, F. & TERASHI, A. (1993). The role of bradykinin in mediating ischemic brain edema in rats. Stroke, 24, 571-576.
28. KARLSRUD, T.S., BUØ, L., AASEN, A.O. & JOHANSEN, H.T. (1996). Bradykinin release from high molecular weight kininogen in surgical ICU patients. Immunopharmacology, 33, 365-368.
29. αq family couple the bradykinin receptor to the release of endothelium-derived relaxing factor. J. Clin. Invest., 92, 2168-2172.
30. 2 bradykinin receptor. Proc. Natl. Acad. Sci. USA, 88, 7724-7728.
31. MAKEVNINA, L.G., LOMOVA, I.P., ZUBKOV, Y.N. & SEMENYUTIN, V.B. (1994). Kininogen consumption in cerebral circulation of humans during brain ischemia and postischemic reperfusion. Brazilian J. Med. Biol. Res., 27, 1955-1963.
32. 1 receptors: a review. Immunopharmacology, 30, 1-26.
33. 2 receptors on the venoconstrictor action of bradykinin. J. Pharmacol. Exp. Ther., 269, 1136-1143.
34. 1 bradykinin receptor. J. Biol. Chem., 269, 21583-21586.
35. NAROTAM, P.K., NADVI, S.S., BHOOLA, K.D. RODELL, T. C.& VAN DELLEN, J.R. (1995). Traumatic brain contusions: A clinical role for a kinin antagonist in reducing secondary brain swelling. J. Neurosurg., 82, 350A.
36. PROUD, D., TOGIAS, A.G., NACLERIO, R.M., CRUSH, S.A., NORMAN, P.S. & LICHTENSTEIN, L.M. (1983). Kinins are generated in vivo following nasal airway challenge of allergic individuals with allergen. J. Clin. Invest., 72, 1678-1685.
37. 2 receptor in the guinea-pig. Br. J. Pharmacol., 116, 2106-2112.
38. 1 receptor-dependent vasoconstriction following balloon catheter injury to the rabbit carotid artery. Br. J. Pharmacol. 111, 1029-1034.
39. RANG, H.P., BEVAN, S.J. & DRAY, A. (1991). Chemical activation of nociceptive peripheral neurons. Br. Med. Bull., 47, 534-548.
40. REGOLI, D. & BARABE, J. (1980). Pharmacology of bradykinin and related kinins. Pharmacol. Rev., 32, 1-46.
41. REGOLI, D., BARABE, J. & PARK, W.K. (1977). Receptors for bradykinin in the rabbit aortae. Can J. Physiol. Pharmacol., 55, 855-867.
42. 2 receptor antagonist, inhibits brain injury in a rat model of reversible middle cerebral artery occlusion. Stroke, 28, 1430-1436.
43. RIZZI, A., GOBEIL, F., BOGONI, G., CALÒ, G., CAMPOBASSO, C., INAMURA, N. & REGOLI, D. (1997). Antagonistic effects of FR173657 on human, pig, rabbit and guinea pig kinin receptors: An in vitro study. Can. J. Physiol. Pharmacol., 75, 601-608.
44. 2 receptor. J. Med. Chem., 36, 2583-2584.
45. 2 receptor antagonist. Proc. Natl. Acad. Sci U.S.A., 91, 4693-4697.
46. SHARMA, J.N. & WIRTH, K.J. (1996). Inhibition of rats adjuvant arthritis by a bradykinin antagonist Hoe 140 and its influence on kallikrein. Gen. Pharmacol., 27, 133-136.
47. SCHILLING, L. & WAHL, M. (1997). Brain edema: Pathogenesis and therapy. Kidney International, 51, (suppl. 59), S69-S75.
48. WALKER, K., PERKINS, M. & DRAY, A. (1995). Kinins and kinin receptors in the nervous system. Neurochem. Int., 26, 116.
49. YANO, K., HIGASHIDA, H., INOUE, R. & NOZAWA, V. (1984). Bradykinin-induced rapid breakdown of phosphatidylinositol 4,5-biphosphate in neuroblastoma x glioma hybrid NG108-15 cells. J. Biol. Chem., 259, 10201-10207.
50. YOTSUMOTO, E., MANABE, T, & OHSHIO, G. (1993). Bradykinin involvement in the aggravation of acute pancreatitis in rabbits. Digestion, 54, 224-230.